News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymetrix (Santa Clara, California) (AFFX) Enables Analysis of Challenging Sample Types Through Exclusive Agreement With Genisphere


11/16/2011 7:32:32 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix®, Inc. (NASDAQ:AFFX) announced today that it has entered into an exclusive, worldwide licensing agreement with Genisphere®, LLC, for RNA amplification and labeling technology to address challenging sample types including formalin-fixed, paraffin-embedded (FFPE) samples for GeneChip® Arrays.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES